Hurford William E
Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Respir Care. 2002 Mar;47(3):334-46; discussion 346-7.
Treatment of anxiety and delirium, provision of adequate analgesia, and, when necessary, amnesia in critically ill patients is humane and may reduce the incidence of post-traumatic stress disorders. Injudicious use of sedatives and paralytics to produce a passive and motionless patient, however, may prolong weaning and length of stay in the intensive care unit. This report reviews indications and choices for pharmacologic treatment of anxiety, delirium, agitation, and provision of anesthesia in critically ill patients. The choice of pharmacologic agents is made difficult by complex or poorly understood pharmacokinetics, drug actions, and adverse effects in critically ill patients. Advantages, adverse effects, and limitations of drug treatment, including use of neuromuscular blocking drugs and use of sedatives and analgesia during the withdrawal of life-sustaining measures are reviewed.
对危重症患者进行焦虑和谵妄的治疗、提供充分的镇痛,以及必要时给予失忆处理,是人道的做法,且可能降低创伤后应激障碍的发生率。然而,不合理地使用镇静剂和麻痹剂以使患者处于被动和静止状态,可能会延长撤机时间和在重症监护病房的住院时间。本报告回顾了危重症患者焦虑、谵妄、躁动的药物治疗指征及选择,以及麻醉的提供。危重症患者复杂或 poorly understood 药代动力学、药物作用和不良反应,使得药物选择变得困难。本文还回顾了药物治疗的优点、不良反应及局限性,包括使用神经肌肉阻滞剂以及在撤除维持生命措施期间使用镇静剂和镇痛剂的情况。 (注:“poorly understood”直译为“理解不充分的”,这里意译为“难以理解的”更通顺,但原文如此,需注意)